Biotech

All Articles

2 cancer biotechs merge, developing international footprint

.OncoC4 is actually taking AcroImmune-- and its internal clinical production functionalities-- under...

Amgen files initial phase 3 win for $400M chronic eczema medicine

.Amgen has actually shared (PDF) the 1st stage 3 records on its $400 million eczema drug, connecting...

Biogen, UCB file period 3 lupus succeed after falling short earlier test

.Biogen as well as UCB's bank on advancing in to phase 3 on the back of a broken research seeks to h...

Aptadir wishes brand new RNA preventions can turn around challenging cancers

.Italian biotech Aptadir Therapies has introduced with the commitment that its pipe of preclinical R...

Wave surfs DMD results to regulatory authorities' doors, delivering stock up

.Surge Life Sciences has met its objective in a Duchenne muscle dystrophy (DMD) research, installing...

Sanofi plucks new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, using up th...

Achilles droplets tissue therapy plan, prepares for cutbacks after skipping 'commercial stability' targets

.Achilles Therapeutics has torn up its method. The English biotech is actually quiting working on it...

Aligos advertises phase 2 MASH win, slashing liver fat up to 46%

.Aligos Rehabs is actually heralding a midstage succeed in metabolic-dysfunction linked steatohepati...

Basilea scores $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job creating new antifungals has actually acquired a substantial increase f...

Capricor sells Europe liberties to late-stage DMD treatment for $35M

.Having currently scooped up the USA civil rights to Capricor Therapies' late-stage Duchenne muscula...